In vitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa

Diagnostic Microbiology and Infectious Disease

Volumn 88, Issue 2, 2017, Pages 188-191

  Kang, Anthony D ^a,b   Smith, Kenneth P ^a   Eliopoulos, George M ^a   Berg, Anders H ^a   McCoy, Christopher ^a   Kirby, James E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b US Army Medical Department Center & School   (United States)

Author keywords

Acinetobacter; Activity spectrum; Aminoglycoside; Apramycin; Pseudomonas aeruginosa; Repurposing

Indexed keywords

AMIKACIN; APRAMYCIN; GENTAMICIN; TOBRAMYCIN; ANTIINFECTIVE AGENT; NEBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; IN VITRO STUDY; MIC50; MIC90; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; ANALOGS AND DERIVATIVES; ANIMAL; COMPARATIVE STUDY; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST;

ACINETOBACTER BAUMANNII; AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; NEBRAMYCIN; PSEUDOMONAS AERUGINOSA; TOBRAMYCIN;

EID: 85015803622     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2017.03.006     Document Type: Article

References (34)

1. Akiyoshi, M., Yano, S., Ikeda, T., Ototoxicity of spectinomycin (author's transl). Jpn J Antibiot 29 (1976), 771–782.
2. Bischoff, K.M., Edrington, T.S., Callaway, T.R., Genovese, K.J., Nisbet, D.J., Characterization of antimicrobial resistant salmonella Kinshasa from dairy calves in Texas. Lett Appl Microbiol 38 (2004), 140–145.
3. Calhoun, J.H., Murray, C.K., Manring, M.M., Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin Orthop Relat Res 466 (2008), 1356–1362.
4. Clinical and Laboratory Standards Institute, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - tenth edition. CLSI document M07-A10, 2015, Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; twenty-sixth informational supplement. CLSI document M100-S26, 2016, Clinical and Laboratory Standards Institute, Wayne, PA.
6. Davies, J., Anderson, P., Davis, B.D., Inhibition of protein synthesis by spectinomycin. Science 149 (1965), 1096–1098.
7. Davies, J., O'Connor, S., Enzymatic modification of aminoglycoside antibiotics: 3-N-acetyltransferase with broad specificity that determines resistance to the novel aminoglycoside apramycin. Antimicrob Agents Chemother 14 (1978), 69–72.
8. Davis, K.A., Moran, K.A., McAllister, C.K., Gray, P.J., Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 11 (2005), 1218–1224.
9. García-Salguero, C., Rodríguez-Avial, I., Picazo, J.J., Culebras, E., Can plazomicin alone or in combination be a therapeutic option against carbapenem-resistant Acinetobacter baumannii?. Antimicrob Agents Chemother 59 (2015), 5959–5966.
10. Landman, D., Kelly, P., Bäcker, M., Babu, E., Shah, N., Bratu, S., et al. Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. J Antimicrob Chemother 66 (2011), 332–334.
11. Lashev, L.D., Pashov, D.A., Marinkov, T.N., Interspecies differences in the pharmacokinetics of kanamycin and apramycin. Vet Res Commun 16 (1992), 293–300.
12. Livermore, D.M., Mushtaq, S., Warner, M., Zhang, J.C., Maharjan, S., Doumith, M., et al. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother 66 (2011), 48–53.
13. Lovering, A.M., White, L.O., Reeves, D.S., AAC(1): a new aminoglycoside-acetylating enzyme modifying the cl aminogroup of apramycin. J Antimicrob Chemother 20 (1987), 803–813.
14. Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., Harbarth, S., Hindler, J.F., Kahlmeter, G., Olsson-Liljequist, B., Paterson, D.L., Rice, L.B., Stelling, J., Struelens, M.J., Vatopoulos, A., Weber, J.T., Monnet, D.L., Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18 (2012), 268–281.
15. Marshall, S.A., Jones, R.N., Wanger, A., Washington, J.A., Doern, G.V., Leber, A.L., et al. Proposed MIC quality control guidelines for National Committee for clinical laboratory standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin. J Clin Microbiol 34 (1996), 2027–2029.
16. Matt, T., Ng, C.L., Lang, K., Sha, S.H., Akbergenov, R., Shcherbakov, D., et al. Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. Proc Natl Acad Sci U S A 109 (2012), 10984–10989.
17. Michiels, J.E., Van den Bergh, B., Verstraeten, N., Fauvart, M., Michiels, J., In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens. Antimicrob Agents Chemother 60 (2016), 4630–4637.
18. Miller, G.H., Sabatelli, F.J., Hare, R.S., Glupczynski, Y., Mackey, P., Shlaes, D., et al. The most frequent aminoglycoside resistance mechanisms–changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside resistance study groups. Clin Infect Dis 24:Suppl. 1 (1997), S46–S62.
19. Murray, C.K., Wilkins, K., Molter, N.C., Li, F., Yu, L., Spott, M.A., et al. Infections complicating the care of combat casualties during operations Iraqi freedom and enduring freedom. J Trauma 71 (2011), S62–S73.
20. O'Connor, S., Lam, L.K., Jones, N.D., Chaney, M.O., Apramycin, a unique aminocyclitol antibiotic. J Org Chem 41 (1976), 2087–2092.
21. Odland, B.A., Erwin, M.E., Jones, R.N., Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications. J Clin Microbiol 38 (2000), 453–455.
22. Perzynski, S., Cannon, M., Cundliffe, E., Chahwala, S.B., Davies, J., Effects of apramycin, a novel aminoglycoside antibiotic on bacterial protein synthesis. Eur J Biochem 99 (1979), 623–628.
23. Petersen, K., Riddle, M.S., Danko, J.R., Blazes, D.L., Hayden, R., Tasker, S.A., et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg 245 (2007), 803–811.
24. Poole, K., Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49 (2005), 479–487.
25. Ramirez, M.S., Tolmasky, M.E., Aminoglycoside modifying enzymes. Drug Resist Updat 13 (2010), 151–171.
26. Rice, L.B., Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 197 (2008), 1079–1081.
27. Rybak, L.P., Ramkumar, V., Ototoxicity. Kidney Int 72 (2007), 931–935.
28. Shaw, K.J., Rather, P.N., Hare, R.S., Miller, G.H., Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57 (1993), 138–163.
29. Smith, K.P., Kirby, J.E., Validation of a high-throughput screening assay for identification of adjunctive and directly acting antimicrobials targeting carbapenem-resistant Enterobacteriaceae. Assay Drug Dev Technol 4 (2016), 194–206.
30. Smith, K.P., Kirby, J.E., Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae. Diagn Microbiol Infect Dis 86 (2016), 439–441.
31. Turnidge, J., Paterson, D.L., Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev 20 (2007), 391–408.
32. Vila, J., Marcos, A., Marco, F., Abdalla, S., Vergara, Y., Reig, R., et al. In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter Baumannii. Antimicrob Agents Chemother 37 (1993), 138–141.
33. Ziv, G., Bor, A., Soback, S., Elad, D., Nouws, J.F., Clinical pharmacology of apramycin in calves. J Vet Pharmacol Ther 8 (1985), 95–104.
34. Ziv, G., Kurtz, B., Risenberg, R., Glickman, A., Serum and milk concentrations of apramycin in lactating cows, ewes and goats. J Vet Pharmacol Ther 18 (1995), 346–351.